510(k) K081104
K081104 is an FDA 510(k) premarket notification submitted by Aesku Diagnostics for the device "AESKULISA ANA HEP-2, REF 30-7115US". The FDA issued a decision of Substantially Equivalent on May 2, 2008. The device falls under product code LKJ (Antinuclear Antibody, Antigen, Control), a Class II device regulated under 21 CFR 866.5100. Aesku Diagnostics has 8 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- May 2, 2008
- Date Received
- Apr 18, 2008
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- Yes
Device classification
- Device Name
- Antinuclear Antibody, Antigen, Control
- Device Class
- Class II
- Regulation Number
- 866.5100
- Review Panel
- IM
- Submission Type
- 510(k)
Need the full FDA record for Aesku Diagnostics? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.